Myriad Genetics Launches Prostate Cancer Test Combining Genomics and AI
The test combines genomic risk assessment and digital pathology analysis to help clinicians tailor monitoring strategies.
Latest Articles
Editor's Top Picks
ACS Updates Colorectal Cancer Screening Guidelines to Include Blood-Based and Stool Tests
The new recommendations add blood-based testing and multi-target stool testing as options for average-risk adults starting at age 45.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Liquid Biopsy Maps Tumor Microenvironment to Predict Immunotherapy Response
Mayo Clinic and Stanford Medicine researchers have developed a liquid biopsy that profiles tumor microenvironments to help predict immunotherapy response, according to a study published in Nature.
Equipment & Supply Spotlight
FDA Clears New Automated Blood Culture System for Faster Sepsis Detection
The BD BACTEC FXI Culture System reduces detection time for bloodstream infections by approximately three hours compared to previous models.
News, Know-How & Standards
Disease Detection & Understanding
Blood Test Outperforms Recommended Tools for Identifying Treatment-Eligible MASH Patients
Hepta’s blood test identified treatment-eligible MASH patients more accurately than current non-invasive methods in a 528-patient study, according to data presented at the EASL 2026 Congress.
